A prospective study of fibroblast growth factor-23 in children with chronic kidney disease

References

• Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007;117:4003–8.
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Yamashita T. FGF23 is a hormone-regulating phosphate metabolism – unique biological characteristics of FGF23. Bone 2007;40:1190–5.
   PubMed Web of Science ®Google Scholar
• Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 2006;116:3150–9.
   PubMedGoogle Scholar
• Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003;112:683–92.
   PubMed Web of Science ®Google Scholar
• The ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000;26:345–8.
   PubMed Web of Science ®Google Scholar
• Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004;65:1943–6.
   PubMedGoogle Scholar
• Larsson T, Nisbeth U, Ljunggren Ö, Jüppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003;64:2272–9.
   PubMed Web of Science ®Google Scholar
• Silver J, Naveh-Many T. Phosphate and the parathyroid. Kidney Int 2009;75:898–905.
   PubMedGoogle Scholar
• Kuizon BD, Salusky IB. Growth retardation in children with chronic renal failure. J Bone Miner Res 1999;14:1680–90.
   PubMedGoogle Scholar
• Kuizon BD, Salusky IB. Renal osteodystrophy: pathogenesis, diagnosis, and treatment. Glorieux FH, Pettifor JM, Jüppner H. Pediatric bone. Biology and diseases. London, UK: Academic Press; 2003, 679–701.
   Google Scholar
• Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 1994;45:253–8.
   PubMed Web of Science ®Google Scholar
• Ziolkowska H, Panczyk-Tomaszewska M, Debinski A, Polowiec Z, Sawicki A, Sieniawska M. Bone biopsy results and serum bone turnover parameters in uremic children. Acta Paediatr 2000;89:666–71.
   PubMedGoogle Scholar
• Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren Ö, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003;348:1656–63.
   PubMed Web of Science ®Google Scholar
• Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren Ö, Tenenhouse HS, Jüppner H, Jonsson KB. Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004;145:3087–94.
   PubMed Web of Science ®Google Scholar
• Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Jüppner H, Lanske B. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 2004;23:421–32.
   PubMed Web of Science ®Google Scholar
• Urena Torres P, Friedlander G, de vernejoul MC, Silve C, Prié D. Bone mass does not correlate with the serum fibro-blast growth factor 23 in hemodialysis patients. Kidney Int 2008;73:102–7.
   PubMed Web of Science ®Google Scholar
• Schwartz GJ, Haycock GB, Edelmann Jr CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259–69.
   PubMed Web of Science ®Google Scholar
• Swolin-Eide D, Hansson S, Larsson L, Magnusson P. The novel bone alkaline phosphatase B1x isoform in children with kidney disease. Pediatr Nephrol 2006;21:1723–9.
   PubMed Web of Science ®Google Scholar
• Westerberg P-A, Linde T, Wikström B, Ljunggren Ö, Stridsberg M, Larsson TE. Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant 2007;22:3202–7.
   PubMed Web of Science ®Google Scholar
• Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Jüppner H, Salusky IB. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009;94:511–7.
   PubMed Web of Science ®Google Scholar
• Feber J, Cochat P, Braillon P. Bone mineral density in children after renal transplantation. Pediatr Nephrol 2000;14:654–7.
   PubMedGoogle Scholar
• Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004;44:250–6.
   PubMed Web of Science ®Google Scholar
• Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 2005;67:1171–8.
   PubMed Web of Science ®Google Scholar
• Cioffi M, Corradino M, Gazzerro P, Vietri MT, Di Macchia C, Contursi A, Colicigno R, Catalano T, Molinari AM. Serum concentrations of intact parathyroid hormone in healthy children. Clin Chem 2000;46:863–4.
   PubMedGoogle Scholar
• Burnett S-AM, Gunawardene SC, Bringhurst FR, Jüppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006;21:1187–96.
   PubMed Web of Science ®Google Scholar